BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TiGenix 

Head Office
Technologielaan 3
Leuven    B - 3001  Belgium
Phone: 32-16-39-60-60 Fax: 32-16-39-60-70


SEARCH JOBS




Industry
Biotechnology






 Company News
TiGenix : Licenses Exclusive Marketing And Distribution Rights For Chondrocelect To Swedish Orphan Biovitrum 4/3/2014 8:13:40 AM    More...
TiGenix : Full Year 2013 Financial Results 3/11/2014 9:00:57 AM    More...
TiGenix Reaches Major Cell Therapy Milestone With 1000th Implant Of Chondrocelect 2/4/2014 9:23:32 AM    More...
PharmaCell BV To Purchase Cell Therapy Production Facility From TiGenix 1/24/2014 9:28:37 AM    More...
TiGenix Secures EUR 10 Million In Financing From Kreos Capital 12/23/2013 9:16:16 AM    More...
TiGenix: Appoints Gri-Cel CEO Dirk Buscher And COO Jose Terencio To Board Of Directors Following Strategic Investment By Grifols 12/5/2013 9:36:31 AM    More...
TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols 11/22/2013 9:28:33 AM    More...
TiGenix Raises EUR 12 Million Via A Private Placement Of New Ordinary Shares 11/20/2013 7:54:56 AM    More...
TiGenix Business Update & Financial Highlights for Q3 of 2013 11/5/2013 9:32:50 AM    More...
TiGenix Invited to Present Cx611 Phase 2a Data in Plenary Session of American College of Rheumatology and Participating in Other Upcoming Key Conferences 9/10/2013 9:13:22 AM    More...
123456